bimekizumab,adalimumab
ucb pharmaceuticals,abbvie
['bimekizumab', ' psa', 'achieve,(-u achieve),(-u-achieve),(-uachieve)']
does bimekizumab, anti-il17f, work in psa? #acr22 abstract #l02 phase 3, randomized, placebo-controlled study biologic naive patients week 52: 53-54% bkz groups achieved acr502 (v. 50% in tnfi) benefits sustained to week 52 no new safety signals
Rheumatologist at Duke University. Health Services Research VA fellow. Interested in reproductive rheumatology and vasculitis. Plant based ??. cas206@duke.edu.